DeviceTalks Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

DeviceTalks Podcast Network — Technology
DeviceTalks Podcast Network

The DeviceTalks Podcast Network is the ultimate destination for all things #MedTech. By subscribing to this single feed, you’ll gain access to every podcast in our diverse and growing portfolio—more than a dozen unique shows featuring senior leaders, groundbreaking technology insights, and in-depth discussions on the most important topics in the medical device industry.

Each episode dives deep into critical areas like business strategy, market trends, surgical robotics, orthopedics, structural heart, neurology, and beyond. You’ll hear from leading voices at top companies—ranging from major OEMs to innovative startups—sharing their solutions, stories, and strategies for tackling the industry’s biggest challenges.

Our Lineup of Shows Includes:
• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neurovascular
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Enovis & Zimmer Biomet
• StrykerTalks

Why Subscribe?
Subscribing here means you’ll never miss an update from any of our shows. Whether you want a broad overview of the entire industry or prefer to tune into a specific series, this single feed has you covered.

If you discover a favorite topic, you can always subscribe to that individual show’s feed for a more tailored experience.

Meet Your Hosts:
• Tom Salemi, Editorial Director, DeviceTalks
• Kayleen Brown, Managing Editor, DeviceTalks

#DeviceTalks, Where Device Makers Connect.

Copyright: © All rights reserved

Latest Episodes:

The episode where Mayo Clinic & Anumana transform ECG with AI; ConcertAI dishes on next-gen trials Nov 15, 2023

Show notes

Welcome to DeviceTalks AI, a DeviceTalks podcast offering a comprehensive look into the intersection of AI and the medical device industry from two unique perspectives. In the first segment, Paul Friedman, MD, Chair of the Department of Cardiovascular Medicine at Mayo Clinic, and Dave McMullin, Chief Business Officer of Anumana, discuss the groundbreaking collaboration between Mayo Clinic and Anumana in applying AI to enhance cardiovascular diagnostics, particularly through ECGs. They explore how AI can detect cardiac conditions early, with a focus on the EAGLE study's findings on AI-enhanced ECGs, and discuss Anumana's role in transforming these AI innovations into accessible medical devices. In the second segment, Jeff Elton, PhD, CEO of ConcertAI, speaks to the transformative role of AI in clinical trials. He sheds light on AI's capabilities in improving patient selection for clinical trials and streamlining processes within life sciences. Dr. Elton emphasizes the broader implications of AI, from enhancing patient care to accelerating the development of new treatments, and discusses the ethical considerations of AI integration in healthcare.These interviews provide insights into the evolving roles of AI in various sectors like medtech, pharma, and biotech, showcasing its potential in transforming healthcare and research methodologies. But that's not all! Join us for the next episode of DeviceTalks AI, which features an interview with the Global Business Leader for Health and Life Sciences at Microsoft. Catch the full episode on all major podcast platforms and the DeviceTalks YouTube to dive deeper into the exciting convergence of AI and medtech. Thank you to our contributors, some of who include Catalyze Healthcare and SmartTRAK Business Intelligence, for providing vital support. To learn more about our contributors, visit: www.catalyzehealthcare.com and www.smarttrak.com. Thank you for listening to DeviceTalks AI.

Hear Why J&J Medtech Is Ready to Move Forward with Ottava; A VC Discusses the Impact of GLP-1 drugs Nov 10, 2023

Show notes

In this week’s episode we’ll speak with Rocco De Bernardis, Global President of OTTAVA, Johnson & Johnson MedTech. This week, J&J MedTech announced it was filing an IDE to begin clinical trials on its surgical robotics system, Ottava, in 2024. But what does this mean? What does Ottava look like? Why does J&J MedTech think it has what it takes to win over surgeons? And what does the future look like for the company’s surgical robotics platform? Co-hosts Tom Salemi and Chris Newmarker also chat with Karthik Bolisetty, senior associate at VC firm Gilde Healthcare, about the impact GLP-1 drugs could have on medical device start-ups. How does Gilde see the weight loss drugs impacting its portfolio and future investments? Finally, Gregg Tobin, CEO of Aptyx, our episode sponsor, talks about how the company’s new name better reflects its capabilities. Go to Aptyx.com for more information. Thanks for listening to the DeviceTalks Weekly podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

Boston Scientific's EP leaders Stein and Spadea-Anello discuss the next leap in cardiac ablation Nov 07, 2023

Show notes

In this episode of Boston Scientific Talks, Boston Scientific's electrophysiology leaders, Ken Stein, MD, SVP, Global Chief Medical Officer and Nick Spadea-Anello, Global President of Electrophysiology, offer a deep dive into the transformative potential of the FARAPULSE Pulsed Field Ablation System. They discuss the strategic development and clinical advantages of this innovative technology, emphasizing its ability to target cardiac tissue while minimizing the risk of collateral damage to vital structures like the esophagus. The duo also explores the synergistic potential of combining PFA with devices like the WATCHMAN for stroke prevention, painting a picture of a more streamlined, patient-centric approach to cardiac care. With a keen eye on the future, they discuss the vision for expanding PFA's applications, including its role in treating a broader spectrum of arrhythmias and its adaptability to various procedural settings. Tune in to learn more about Boston Scientific's forward-thinking approach to cardiac ablation. Thank you to Dassault Systèmes for sponsoring this episode. To learn how Dassault Systèmes enables innovation in medtech, visit www.medtecheco.com/lifecycle. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.

Intuitive's Dave Rosa shares insights on surgical robotics’ evolution, offers advice to new players Nov 03, 2023

Show notes

In this special episode of IntuitiveTalks, recorded live from DeviceTalks West, Dave Rosa, President of Intuitive, shares the experience of the company's pioneering role in surgical robotics. Rosa reflects on the initial skepticism faced by the company and the subsequent validation of their work as the industry has grown to embrace robotic assistance in surgery. He also discusses the balance between innovation and the practicalities of scaling a business, emphasizing the importance of reliability and supply chain management in healthcare technology. Rosa also addresses the future of surgical robotics, hinting at a shift towards more compact and specialized devices that could transform patient care. He highlights the economic benefits of robotic surgery, particularly its potential to reduce the overall costs of healthcare while improving surgical outcomes. A must for all medtech stakeholders, this episode offers a thoughtful perspective on leading a company at the forefront of medical technology. Rosa's conversation is a blend of personal experience and professional insights, providing valuable lessons on growth, adaptation, and the continuous effort to improve surgical care. Thanks to maxon Group for sponsoring this episode. Visit https://www.maxongroup.us/maxon/view/content/medical to learn more about how maxon Group works with medical device companies. Thank you for listening to the IntuitiveTalks Podcast. Subscribe to this podcast on every major podcast platform.

Abbott’s Tyler outlines vascular’s move to predictive modeling, diversifying trials & next-gen tech Oct 31, 2023

Show notes

In this special episode of AbbottTalks, recorded live from DeviceTalks West, Julie Tyler, president of Abbott's Vascular business, discusses the company's strategic evolution and commitment to comprehensive patient care, including a new technology, the Esprit BTK, intended to be released next year. Additionally, Tyler provides an insider's perspective on Abbott's integration of Cardiovascular Systems Inc., revealing how this move enhances Abbott's portfolio and positions the company at the forefront of vascular health. Tyler's vision extends beyond current interventions, aiming to leverage data and predictive modeling to improve patient outcomes and potentially reduce the need for later-stage interventions. With a patient-centric approach, Tyler also discusses the challenges and successes in diversifying clinical trial demographics and expanding global reach. This episode is a must-listen for those interested in how strategic acquisitions and a holistic health model can redefine patient care. Thank you to Resonetics for sponsoring this episode. To learn more about how Resonetics works with medical device companies, visit https://resonetics.com/. Thank you for listening to the AbbottTalks Podcast. Subscribe to this podcast on every major podcast platform.

Qiagen CEO on learning to love diagnostics and why he’s worried we forgot lessons from the pandemic Oct 27, 2023

Show notes

In this week’s episode, Qiagen CEO Thierry Bernard gives us a look inside the diagnostics leader both today and a few years ago when it was responded to the world’s dire need for diagnostics. Bernard takes us back to the early days of the pandemic, including his perspective on how different countries responded to the crisis. We’ll also hear his vision for the future of diagnostics including how Qiagen will make testing even simpler. At the start of the show, Host Tom Salemi and Chris Newmarker, executive editor of life sciences, talk with Senior Editor Danielle Kirsh about the recently released Women in Medtech issue of Medical Design and Outsourcing magazine. Kirsh shares data she’s collected on how many women hold senior positions in the medical device industry. We’re seeing some progress, but not enough. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.

It’s the DeviceTalks West Post Game Wrap Up Show, Starring Tom, Chris, Kayleen, Sean and Joe!! Oct 20, 2023

Show notes

We recorded this episode on stage at the conclusion of DeviceTalks West. Our semi-esteemed panel included Co-Hosts Tom Salemi and Chris Newmarker as well as Sean Whooley of the Fast Five Podcast, Kayleen Brown of DeviceTalks, and Joe Mullings of The Mullings Group. We hit upon the highlights of DeviceTalks West. We hope you were there to enjoy the show yourself! Thanks to everyone who made #DTWest2023 such a huge success! Go Medtech!

Join us at DeviceTalks West on Oct. 18-19! A pre-interview interview with Intuitive’s Dave Rosa Oct 13, 2023

Show notes

Join us at DeviceTalks West on Oct. 18-19 at the Santa Clara Convention Center! In this episode, Tom Salemi invites all DeviceTalkers to our biggest West Coast meeting yet! Listen for the discount code (Oh heck, it’s DTW25). We’ll also run a replay of our interview with Dave Rosa, now president of Intuitive, who will be our opening keynote interview on Oct. 19. Register now at West.DeviceTalks.com! GO MEDTECH!

How Nitin Salunke’s different mindset helped him shift career from engineer to CEO of Supira Medical Oct 06, 2023

Show notes

A college introduction to biomechanics set Nitin Salunke on an expected path into the medical device industry. But once his course was set Salunke helped manage innovative product launches at several large medical device companies including WL Gore, Cordis and Covidien/Medtronic. But Salunke always had his eyes on leading a start-up. In this discussion you’ll learn how he used each opportunity to help achieve that dream. Today, he leads Supira Medical, a white-hot startup developing a new type of pVAD. Salunke will also be a speaker at the upcoming DeviceTalks West meeting. Thanks for listening to this episode of DeviceTalks Weekly. Subscribe to the DeviceTalks Podcast Network on any major podcast channel.

Boston Scientific's Sandra Nagale predicts the future of medtech powered by AI innovations Oct 05, 2023

Show notes

In this episode of Boston Scientific Talks, Sandra Nagale, PhD, Director of Digital Health Platforms and Products, breaks down the transformative role of AI within the medical device industry. Motivated to drive impactful changes, Nagale emphasizes Boston Scientific's unwavering dedication to pioneering breakthrough medical solutions and enhancing patient and physician experiences through AI and emphasizes how products like BeatLogic and LUX-Dx ICM are redefining healthcare by providing actionable, real-time insights. Navigating the complexities of melding AI with healthcare, Nagale accentuates the necessity for solutions rooted in evidence that genuinely amplifies value. She highlights the urgency to streamline patient experiences, mitigate healthcare worker challenges, and elevate the patient journey. As Boston Scientific spearheads these advancements, Nagale envisions a future where medical devices seamlessly integrate into holistic patient care – from early detection to treatment. Dive into this episode to uncover how Boston Scientific is steering the medtech industry into an AI-augmented future. Thank you to S3 Connected Health for sponsoring this episode of Boston Scientific Talks. For more information about S3 Connected Health, go to s3connectedhealth.com. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.

Related Podcasts